Search scope:
排序: Display mode:
Frontiers of Medicine 2022, Volume 16, Issue 2, Pages 285-294 doi: 10.1007/s11684-021-0843-8
Keywords: CAR-T cell therapy refractory diffuse large B-cell lymphoma cytokine release syndrome dose-limiting
Frontiers of Medicine 2023, Volume 17, Issue 4, Pages 699-713 doi: 10.1007/s11684-022-0972-8
Keywords: anti-CD19 chimeric antigen receptor T immunotherapy diffuse large B cell lymphoma tumor microenvironment
Yiwen Cao, Zhenhua Liu, Wen Wu, Ying Qian, Qin Shi, Rong Shen, Binshen Ouyang, Pengpeng Xu, Shu Cheng, Jin Ye, Yiming Lu, Chaofu Wang, Chengde Yang, Li Wang, Weili Zhao
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 94-103 doi: 10.1007/s11684-019-0680-1
Autoimmune diseases (ADs) increase the risk of non-Hodgkin’s lymphoma and contribute to poor prognosisto analyze the prognostic value of pretreatment immunologic markers in newly diagnosed patients with diffuselarge B-cell lymphoma (DLBCL).In conclusion, the immunologic status was closely related to lymphoma progression, and this study provides
Keywords: immunologic marker diffuse large B-cell lymphoma prognosis
Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition)
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 815-826 doi: 10.1007/s11684-021-0891-0
Keywords: B-cell lymphoma oral drug targeted therapy immunotherapy COVID-19 pandemic
CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignancies
Frontiers of Medicine 2021, Volume 15, Issue 6, Pages 783-804 doi: 10.1007/s11684-021-0904-z
Keywords: CAR T cells hematological malignancies review
Frontiers of Medicine 2022, Volume 16, Issue 1, Pages 139-149 doi: 10.1007/s11684-021-0835-8
Keywords: B-cell acute lymphoblastic leukemia bispecific antibody trispecific antibody CD19 CD20
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Jianfeng Li, Yuting Dai, Liang Wu, Ming Zhang, Wen Ouyang, Jinyan Huang, Saijuan Chen
Frontiers of Medicine 2021, Volume 15, Issue 3, Pages 347-371 doi: 10.1007/s11684-020-0821-6
Keywords: BCP-ALL subtypes translocation aneuploidy sequence mutations
Lili Zhou, Ping Li, Shiguang Ye, Xiaochen Tang, Junbang Wang, Jie Liu, Aibin Liang
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 786-791 doi: 10.1007/s11684-020-0751-3
Keywords: anti-CD19 chimeric antigen receptor T cell soft tissue bone marrow relapsed or refractory non-Hodgkinlymphoma
Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock
Muhammad Furqan,Yamei Chen,Akintunde Akinleye,Judy Sarungbam,Alan Gass,Karen Seiter,Delong Liu
Frontiers of Medicine 2014, Volume 8, Issue 2, Pages 254-258 doi: 10.1007/s11684-014-0319-1
Mantle cell lymphoma is an aggressive subtype of B cell non-Hodgkin lymphoma.find a report of myocardial infiltration by this disease since the appraisal of the term “mantle celllymphoma” in 1992.Here we report a case of cardiac involvement by mantle cell leukemia leading to cardiogenic shock which
Keywords: mantle cell lymphoma bendamustine cardiogenic shock
Aldolase B attenuates clear cell renal cell carcinoma progression by inhibiting CtBP2
Frontiers of Medicine 2023, Volume 17, Issue 3, Pages 503-517 doi: 10.1007/s11684-022-0947-9
Keywords: ALDOB kidney cancer cell proliferation
Xiaofeng Shi, Rong Ba, Haiyan You, Qian Jiang, Jiansong Huang, Jianhua Mao, Lanxiu Han, Shuo Zhang, Qin Zhuang, Xianqiu Yu, Lixia Wang, Yun Wang, Dongya Li, Wei Zhu, Yong Zhang, Yan Zhu, Xiaodong Xi
Frontiers of Medicine 2018, Volume 12, Issue 3, Pages 324-329 doi: 10.1007/s11684-017-0558-z
Splenic lymphoma with villous lymphocytes (SLVL) or splenic marginal zone lymphoma with circulatingIn this study, we report a case of B-lymphoproliferative disorder with villous lymphocytes harboringIn this report, we described an unusual case of B-lymphoproliferative disorder with villous lymphocytes14)(q24;q32) translocation, which could provide help in the diagnosis and differential diagnosis of B-lymphocytic
Keywords: splenic lymphoma with villous lymphocytes splenic marginal zone lymphoma transformation chromosome translocation
Paradoxical role of Id proteins in regulating tumorigenic potential of lymphoid cells
Sumedha Roy, Yuan Zhuang
Frontiers of Medicine 2018, Volume 12, Issue 4, Pages 374-386 doi: 10.1007/s11684-018-0652-x
Keywords: Id proteins lymphoma leukemia T cells B cells tumor suppressor oncogene
Frontiers of Medicine 2023, Volume 17, Issue 4, Pages 747-757 doi: 10.1007/s11684-022-0954-x
Keywords: COVID-19 convalescent SARS-CoV-2 inactivated vaccination neutralizing antibody B cell response
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Houli Zhao, Yiyun Wang, Elaine Tan Su Yin, Kui Zhao, Yongxian Hu, He Huang
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 711-725 doi: 10.1007/s11684-020-0808-3
Keywords: chimeric antigen receptor T (CAR-T) cell lymphoma cytokine release syndrome (CRS) immune effector cell-associated
Jay H. Ryu, Xinlun Tian, Misbah Baqir, Kaifeng Xu
Frontiers of Medicine 2013, Volume 7, Issue 3, Pages 316-327 doi: 10.1007/s11684-013-0269-z
Diffuse cystic lung diseases are uncommon but can present a diagnostic challenge because increasing“Diffuse” distribution in the lung implies involvement of all lobes.Diffuse lung involvement with cystic lesions can be seen in pulmonary lymphangioleiomyomatosis, pulmonaryLangerhans’ cell histiocytosis, lymphoid interstitial pneumonia, Birt-Hogg-Dubé syndrome
Keywords: cyst lung disease interstitial lung disease lymphangioleiomyomatosis Langerhans’ cell histiocytosis Birt-Hogg-Dubé
Title Author Date Type Operation
Phase I study of CBM.CD19 chimeric antigen receptor T cell in the treatment of refractory diffuse largeB-cell lymphoma in Chinese patients
Journal Article
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma
Journal Article
Presence of multiple abnormal immunologic markers is an independent prognostic factor of diffuse largeB-cell lymphoma
Yiwen Cao, Zhenhua Liu, Wen Wu, Ying Qian, Qin Shi, Rong Shen, Binshen Ouyang, Pengpeng Xu, Shu Cheng, Jin Ye, Yiming Lu, Chaofu Wang, Chengde Yang, Li Wang, Weili Zhao
Journal Article
Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition)
Journal Article
CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignancies
Journal Article
characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell
Journal Article
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Jianfeng Li, Yuting Dai, Liang Wu, Ming Zhang, Wen Ouyang, Jinyan Huang, Saijuan Chen
Journal Article
extranodal involvement may affect the survival of patients with relapsed or refractory non-Hodgkin lymphomaafter chimeric antigen receptor T cell therapy
Lili Zhou, Ping Li, Shiguang Ye, Xiaochen Tang, Junbang Wang, Jie Liu, Aibin Liang
Journal Article
Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock
Muhammad Furqan,Yamei Chen,Akintunde Akinleye,Judy Sarungbam,Alan Gass,Karen Seiter,Delong Liu
Journal Article
Aldolase B attenuates clear cell renal cell carcinoma progression by inhibiting CtBP2
Journal Article
A rare case of B-lymphoproliferative disorder with villous lymphocytes harboring t(8;14)(q24;q32) translocation
Xiaofeng Shi, Rong Ba, Haiyan You, Qian Jiang, Jiansong Huang, Jianhua Mao, Lanxiu Han, Shuo Zhang, Qin Zhuang, Xianqiu Yu, Lixia Wang, Yun Wang, Dongya Li, Wei Zhu, Yong Zhang, Yan Zhu, Xiaodong Xi
Journal Article
Paradoxical role of Id proteins in regulating tumorigenic potential of lymphoid cells
Sumedha Roy, Yuan Zhuang
Journal Article
Neutralization against SARS-CoV-2 Delta/Omicron variants and B cell response after inactivated vaccination
Journal Article
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Houli Zhao, Yiyun Wang, Elaine Tan Su Yin, Kui Zhao, Yongxian Hu, He Huang
Journal Article